Physician profile
Blake A Jones
NPI 1659370930
$2,864.51
in general payments reported to CMS, 2019-2025
16 companies · $341 in 2025
The $341 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2021: $59.13 · 2022: $246 · 2023: $32.19 · 2024: $1,942 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,184 · Travel and Lodging: $1,080 · Education: $50.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,183.76 |
| Travel and Lodging | $1,080.27 |
| Education | $50.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Research Institute, INC. | $1,431.88 | 2024 | |
| Boston Scientific Corporation | $442.55 | 2019-2024 | |
| Janssen Biotech, INC. | $390.55 | 2024-2025 | Tremfya, Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $319.75 | 2019-2025 | Entyvio |
| Abbvie INC. | $96.47 | 2021-2025 | |
| Olympus America INC. | $79.36 | 2019 | |
| Medtronic, INC. | $42.25 | 2024 | Synchromedii |
| Mauna Kea Technologies, INC. | $30.92 | 2024 | |
| Endogastric Solutions, INC | $17.79 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.99 | 2022 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.